Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
<p>Radiotherapy is one of the pillars of modern cancer therapy. However, side effects associated with normal tissue toxicity limit the effectiveness of this treatment. It is therefore desirable to develop tumour-specific radiosensitising agents, which can increase tumour cell kill without incr...
Váldodahkki: | Bittner, M |
---|---|
Eará dahkkit: | Higgins, G |
Materiálatiipa: | Oahppočájánas |
Almmustuhtton: |
2017
|
Geahča maid
-
Histone Deacetylases and Their Potential as Targets to Enhance Tumour Radiosensitisation
Dahkki: Jennifer Antrobus, et al.
Almmustuhtton: (2022-03-01) -
The NLRP11 Protein Bridges the Histone Lysine Acetyltransferase KAT7 to Acetylate Vimentin in the Early Stage of Lung Adenocarcinoma
Dahkki: Rui Yang, et al.
Almmustuhtton: (2023-09-01) -
Myst2/Kat7 histone acetyltransferase interaction proteomics reveals tumour-suppressor Niam as a novel binding partner in embryonic stem cells
Dahkki: Mercedes Pardo, et al.
Almmustuhtton: (2017-08-01) -
The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer
Dahkki: Groselj, B
Almmustuhtton: (2014) -
Histone deacetylase inhibitors as radiosensitisers: Effects on DNA damage signalling and repair
Dahkki: Groselj, B, et al.
Almmustuhtton: (2013)